TY  - JOUR
AU  - Mendiburu-Eliçabe Garganta, Marina
AU  - Yin, Dali
AU  - Hadaczek, Piotr
AU  - Zhai, Yuying
AU  - Forsayeth, John
AU  - Bankiewicz, Krystof S.
PY  - 2012
DO  - 10.1007/s11060-012-0804-9
SN  - 0167-594X
UR  - https://hdl.handle.net/20.500.14352/100465
AB  - The mammalian target of rapamycin (mTOR) plays a central role in regulating the proliferation of cancer cells, and mTOR-specific inhibitors such as rapamycin analogs are considered as a promising therapy for malignant glioma. In this study, we...
LA  - eng
M2  - 53
KW  - Glioma
KW  - Rapamycin and systemic administration
TI  - Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study
TY  - journal article
VL  - 108
ER  -